Authors
Pratiksha Gautam, Prasanna Dahal, Deevan Paul, Kadir Alam
Publication date
2023
Journal
Pharmacophore
Volume
14
Issue
2
Pages
11-18
Description
Diabetes and hypertension both are non-communicable diseases of major health concern worldwide [1]. They are the leading causes of coronary heart disease, stroke, end-stage renal failure, disability, and higher healthcare expenses [2]. According to researchers, high blood pressure (BP) presently kills 9 million individuals per year, and by 2025, up to 1.56 billion adults globally will be hypertensive. Raised blood pressure is thought to be responsible for 7.5 million deaths and 57 million disability-adjusted life years (DALYs). On the other hand, the global prevalence of diabetes was 8.3 percent in 2013 (ie, 382 million individuals) and is expected to rise to 592 million by 2035 [3]. The World Health Organization (WHO) member nations adopted the Global Action Plan for the Prevention and Control of Non-communicable Diseases in 2011, to halt the rise of diabetes by 2025 and reduce hypertension prevalence by 25% between 2010 and 2025 [4]. Patients' health-related knowledge, attitude, and practice (HR-KAP) play an important role among people living with a chronic disease like diabetes for an effective health promotion and disease control program [5]. Diabetes and hypertension can have a negative impact on a patient's health and quality of life [6]. As the population ages, chronic diseases including hypertension and type 2 diabetes mellitus are
Total citations